Israeli, American Researchers Discover Blood Marker that could Signal Alzheimer’s Diagnosis

Longevity Investing

The Jerusalem Post reported that a biological blood marker linked to Alzheimer’s disease could eventually serve as a reliable diagnostic blood test for the progressive, fatal dementia has been identified by researchers at Tel Aviv University, Rambam Medical Center/the Techion-Israel Institute of Technology and Harvard University.

The Jerusalem Post reported that a biological blood marker linked to Alzheimer’s disease could eventually serve as a reliable diagnostic blood test for the progressive, fatal dementia has been identified by researchers at Tel Aviv University, Rambam Medical Center/the Techion-Israel Institute of Technology and Harvard University.
According to the article:

Today, diagnosing Alzheimer’s is a long and complicated process, and most doctors use subjective memory tests of cognitive and functional abilities and behavior changes, she said on Tuesday. In special cases, expensive brain scans are carried out that are not yet available in Israel. Sometimes, invasive tests of the brain and spinal fluids are conducted, noted Gozes of the department of human molecular genetics and biochemistry at TAU’s Sackler Faculty of Medicine and of the Sagol School of Neuroscieces.

TAU lead researcher Prof. Illana Gozes commented:

We hope that in the future, it will be possible to use our discovery to develop a simple blood test for this serious disease even in its early stages.

Click here to view the full article. 

The Conversation (0)
×